FORUM Pharmaceuticals
develops, and commercializes small molecule therapeutics for the disorders of the central nervous system... Read moreFORUM Pharmaceuticals
develops, and commercializes small molecule therapeutics for the disorders of the central nervous system... Read more
CEO
Add
News
May 26, 2016
PharmaLive
FORUM Pharmaceuticals: FORUM Pharma CEO Quits Amid Layoffs and a Possible Company Shutdown
May 26, 2016
BioSpace
FORUM Pharmaceuticals: Failed Trial Forces Massachusetts' FORUM Pharma to Cut Up to 89 Employees, CEO Steps Down
May 24, 2016
BioPortfolio
FORUM Pharmaceuticals: After Failed Trial Forum CEO Dunsire Leaves Companys Fate Unclear
Mar 26, 2016
BioPortfolio
FORUM Pharmaceuticals: FORUM Pharma says encenicline fails to meet Phase III endpoints
Mar 25, 2016
Genetic Engineering & Biotechnology News
FORUM Pharmaceuticals: FORUM Pharmaceuticals to Restructure After Phase III Failures
Mar 24, 2016
BioSpace
FORUM Pharmaceuticals: Bay State's FORUM Pharma Plans to Let Go of Up to 89 Employees
Mar 24, 2016
BioCentury
FORUM Pharmaceuticals: Forum downsizing after Phase III schizophrenia miss
Mar 24, 2016
FierceBiotechIT
FORUM Pharmaceuticals: With two PhIII schizophrenia trials in ruins and Alzheimer's on hold, Forum chops staff and considers options
Mar 23, 2016
Xconomy
FORUM Pharmaceuticals: Restructuring Looms for Forum as Neuro Drug Fails Key Clinical Test
Mar 23, 2016
BioPortfolio
FORUM Pharmaceuticals: FORUM Pharmaceuticals Inc. Provides Update on Encenicline Phase 3 Clinical Trial Program in Cognitive Impairment in Schizophrenia